IRVINE, Calif.–(BUSINESS WIRE)–Reverse Medical
Corporation today announced that it has sold its line of neurovascular guide
catheters to Covidien, a leading global provider of healthcare products. The
terms of the transaction were not disclosed.
“Despite being a young company, Reverse Medicals guide
catheter business already includes a strong customer base, manufacturing
platform, and suite of products and technologies. The lead product, ReFlex™,
has been a great commercial success for us,” said Jeffrey Valko, President and
CEO of Reverse Medical.
Reverse Medical will retain possession of its thrombectomy
technologies and products and will continue its innovative development of new
technologies for the treatment of neurovascular disorders, including both
ischemic and hemorrhagic stroke.
Brian Strauss, Reverse Medicals Chief Technology Officer
added, “This transaction validates our ability to listen to our customer needs
and rapidly develop and commercialize technologies specifically designed for
the treatment of neuro endovascular disorders.”
About Reverse Medical
Reverse Medical Corporation was founded in 2007 by the MedFocus Fund, and is a
privately-held medical device company focused on expanding the endovascular
management of acute stroke and neurovascular disease. The technology platform
includes innovative, state-of-the-art treatments for a broad spectrum of
neurovascular disorders and carotid artery disease. The company is based in Irvine, California.
Posted by Sean Fenske, Editor-in-Chief, MDT
